Tamr CDISC Conversion Solution

Tamr’s CDISC Conversion Solution tackles data challenges with a powerful data harmonization process, driven by human-guided machine learning that can replace traditional in-house tools prone to delays and errors.

Read More


Tamr for CDISC White Paper

In the United States, the FDA requires that every clinical trial or application to market a new drug or biologic be accompanied by clinical study data showing the safety and efficacy of the proposed product. Converting clinical data into the…

Read More


BioPharma Case Study

Tamr was approached by a multinational biopharmaceutical company to transform the process of preparing its clinical data for analytics. The organization wanted to analyze the trove of unmined clinical trial and biomarker data in order to more effectively guide translational…

Read More


CDISC Webinar

For most pharmaceutical companies, submitting clinical study data to the FDA is an expensive and time-consuming process. A study sponsor must collect data from different sources, extract it from proprietary file formats, transform it to conform to CDISC standards, organize…

Read More


CDISC Data Sheet

Clinical Trial Data: Automated, Replicable CDISC Conversion Synopsis + IND and NDA programs necessitate recurrent submission of clinical trial data to regulatory agencies in specific formats. + Trial data is stored in a tangled web of standards, versions, and file…

Read More


Webinar: Toward Automated, Scalable CDISC Conversion

Watch Now » For most pharmaceutical companies, submitting clinical study data to the FDA is an expensive and time-consuming process. A study sponsor must collect data from different sources, extract it from proprietary file formats, transform it to conform to…

Read More